Literature DB >> 30065586

Development of Vitiligo-Like Depigmentation after Treatment of Lentigo Maligna Melanoma with 5% Imiquimod Cream.

Na Hee Kim1, Jee Bum Lee1, Sook Jung Yun1.   

Abstract

A 69-year-old man presented with a black irregular patch on his left cheek. Skin biopsy revealed lentigo maligna melanoma in situ. He was treated via partial excision of the melanoma, followed by the application of 5% imiquimod cream every other night for 6 to 8 hours. The patient experienced severe local inflammation accompanied by burning, edema, and erythema, as well as oozing and crusting. The patient discontinued using the imiquimod cream after 15 applications because of the inflammation. Depigmentation was noted in the treated area 3 months after the initiation of treatment with imiquimod cream. Histological examination using Melan-A staining of the depigmented area revealed an absence of melanocytes, which is consistent with vitiligo. The depigmented lesions improved considerably after a 5-year follow-up, and there was no recurrence of melanoma.

Entities:  

Keywords:  Lentigo maligna; Melanoma; Toll-like receptor; Vitiligo

Year:  2018        PMID: 30065586      PMCID: PMC6029957          DOI: 10.5021/ad.2018.30.4.454

Source DB:  PubMed          Journal:  Ann Dermatol        ISSN: 1013-9087            Impact factor:   1.444


  15 in total

1.  Imiquimod: a cytokine inducer.

Authors:  Mark V Dahl
Journal:  J Am Acad Dermatol       Date:  2002-10       Impact factor: 11.527

2.  Permanent facial hypopigmentation following treatment with imiquimod cream.

Authors:  C O Mendonça; V M Yates
Journal:  Clin Exp Dermatol       Date:  2006-06-15       Impact factor: 3.470

3.  Imiquimod-induced vitiligo in a patient with genital warts.

Authors:  C Stefanaki; E Nicolaidou; M Hadjivassiliou; C Antoniou; A Katsambas
Journal:  J Eur Acad Dermatol Venereol       Date:  2006-07       Impact factor: 6.166

4.  Vitiligo-like hypopigmentation associated with imiquimod treatment of genital warts.

Authors:  Tamu Brown; Monib Zirvi; George Cotsarelis; Joel M Gelfand
Journal:  J Am Acad Dermatol       Date:  2005-04       Impact factor: 11.527

5.  Vitiligo-like hypopigmentation with poliosis following treatment of superficial basal cell carcinoma with imiquimod.

Authors:  Sharon E Jacob; Mariana Blyumin
Journal:  Dermatol Surg       Date:  2008-03-24       Impact factor: 3.398

6.  Genital vitiligo-like depigmentation following use of imiquimod 5% cream.

Authors:  Vasco Vieira Serrão; Filipa Rocha Páris; Ana Barata Feio
Journal:  Eur J Dermatol       Date:  2008-05-13       Impact factor: 3.328

7.  Melanoma in situ treated successfully using imiquimod after nonclearance with surgery: review of the literature.

Authors:  Lixia Z Ellis; Joel L Cohen; Whitney High; Leslie Stewart
Journal:  Dermatol Surg       Date:  2012-02-16       Impact factor: 3.398

8.  Death receptor-independent apoptosis in malignant melanoma induced by the small-molecule immune response modifier imiquimod.

Authors:  Michael P Schön; B Gregor Wienrich; Claudia Drewniok; Anne B Bong; Jürgen Eberle; Christoph C Geilen; Harald Gollnick; Margarete Schön
Journal:  J Invest Dermatol       Date:  2004-05       Impact factor: 8.551

9.  Possible mechanisms in the induction of vitiligo-like hypopigmentation by topical imiquimod.

Authors:  J Mashiah; S Brenner
Journal:  Clin Exp Dermatol       Date:  2007-11-02       Impact factor: 3.470

10.  Imiquimod induces apoptosis of human melanocytes.

Authors:  Chul-Ho Kim; Joo Hee Ahn; Sung Un Kang; Hye Sook Hwang; Mi Hye Lee; Jung Hee Pyun; Hee Young Kang
Journal:  Arch Dermatol Res       Date:  2009-12-23       Impact factor: 3.017

View more
  3 in total

1.  Regional vitiligo induced by imiquimod treatment for in-transit melanoma metastases.

Authors:  Elizabeth Tkachenko; Jennifer Y Lin; Rebecca I Hartman
Journal:  JAAD Case Rep       Date:  2019-04-29

Review 2.  The Role of Toll-Like Receptors in Oncotherapy.

Authors:  Caiqi Liu; Ci Han; Jinfeng Liu
Journal:  Oncol Res       Date:  2019-03-25       Impact factor: 5.574

3.  Imiquimod induced vitiligo-like lesions-A consequence of modified melanocyte function.

Authors:  Haiyan Yu; Jianping Cen; Xiaoxia Lin; Hao Cheng; Oliver Seifert
Journal:  Immun Inflamm Dis       Date:  2021-10-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.